Pendulum Therapeutics Overview
- Founded
- 2012
- Status
- Private
- Employees
- 65
- Latest Deal Type
- Series B
- Latest Deal Amount
- $35M
- Investors
- 13
Pendulum Therapeutics General Information
Description
Developer of microbiome interventions created to improve healthcare by managing chronic illnesses. The company integrates laboratory science and computational analysis to gain a comprehensive view of each individual's microbiome through targeted probiotics and prebiotics, thus enabling clinicians to identify specific microbiome markers and interventions to treat diseases.
Contact Information
Website
Formerly Known As
Whole Biome
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Delivery
Primary Office
- 933 20th Street
- San Francisco, CA 94107
- United States
+1 (844) 000-0000
Pendulum Therapeutics Timeline
Pendulum Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | 30-May-2019 | $35M | 000.00 | 00000 | Completed | Generating Revenue |
| 7. Early Stage VC (Series A2) | 08-Jun-2017 | 000.00 | 000.00 | 0000 | Completed | Generating Revenue |
| 6. Early Stage VC (Series A) | 27-Jan-2016 | 000 | 000.00 | 0000 | Completed | Startup |
| 5. Grant | 01-Jan-2016 | 00000 | 00.00 | Completed | Startup | |
| 4. Seed Round | 15-Dec-2014 | 00.00 | 00.00 | 000.00 | Completed | Startup |
| 3. Accelerator/Incubator | 18-Jun-2014 | Completed | Startup | |||
| 2. Accelerator/Incubator | 13-Oct-2013 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Pendulum Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series A-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series A | 11,797,144 | $0.000100 | $0.05 | $0.68 | $0.68 | 1x | $0.68 | 16.63% |
| Seed | 5,785,203 | $0.000100 | $0.05 | $0.64 | $0.64 | 1x | $0.64 | 8.16% |
Pendulum Therapeutics Executive Team (8)
Pendulum Therapeutics Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Adam D'Augelli | True Ventures | Board Member | 000 0000 |
| Colleen Cutcliffe Ph.D | Pendulum Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| Heather Mason | Pendulum Therapeutics | Board Member | 000 0000 |
| Hugh Martin | Self | Chairman | 000 0000 |
| John Eid Ph.D | Pendulum Therapeutics | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
Pendulum Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPendulum Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Mayo Clinic Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Felicis Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Khosla Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| SK Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| True Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |